Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Ardian strengthens its commitment to Dedalus, driving the next phase of growth with a new investment and the appointment of a new Group CEO

Leave a comment


As part of this growth plan, Alberto Calcagno, former CEO of Italian ICT company Fastweb, which has seen significant constant growth over the past 10 years, has been appointed as new CEO, effective from October 18.

Andrea Fiumicelli, who has managed Dedalus over the last few years and contributed significantly to the company’s further development through several strategic M&A deals, has been appointed Chairman.

“Ardian is fully committed to supporting Dedalus throughout its next period of growth, in which it aims to serve its clients and deliver its mission of improving healthcare for over 500 million patients globally. Ardian and I want to thank Giorgio Moretti for his vision and execution since our initial investment”.

  • MARCO BELLINO, MANAGING DIRECTOR, ARDIAN BUYOUT

“After a long journey that began in Florence 40 years ago, the time has come for Dedalus to expand. This agreement will help the company to further invest in innovation, in line with our mission. Alberto Calcagno will bring strong skills and new energy to the Group’s operations and future strategic development. I will remain a shareholder in Dedalus, together with my longtime partner Three Hills, fully supporting the new CEO and the company’s project”.

  • GIORGIO MORETTI, FOUNDER, DEDALUS

“I am very happy to join Dedalus to drive its ambitious growth plans. Today, the healthcare software industry is privileged to have the responsibility of leading on critical digital transformation to improve the well-being of millions of patients. Dedalus’ mission is to accelerate and deliver this change as soon as possible”.

  • ALBERTO CALCAGNO, NEW CEO, DEDALUS

“In the last four years we have successfully re-designed our software portfolio and established sales and delivery operations in 25 countries. This new governance structure strengthens our commitment to our mission and future clients. We aim to deliver faster innovation and high-quality services, be the best employer in the sector and serve our shareholders’ ambitions”.

  • ANDREA FIUMICELLI, NEW CHAIRMAN, DEDALUS

Ardian has invested in Dedalus in several stages since 2016, supporting a strong M&A strategy which has seen the Company become a pan-European leader in its sector.

ABOUT ARDIAN
Ardian is a world-leading private investment house, managing or advising $156bn of assets on behalf of more than 1,470 clients globally. Our broad expertise, spanning Private Equity, Real Assets and Credit, enables us to offer a wide range of investment opportunities and respond flexibly to our clients’ differing needs. Through Ardian Customized Solutions we create bespoke portfolios that allow institutional clients to specify the precise mix of assets they require and to gain access to funds managed by leading third-party sponsors. Private Wealth Solutions offers dedicated services and access solutions for private banks, family offices and private institutional investors worldwide. Ardian’s main shareholding group is its employees and we place great emphasis on developing its people and fostering a collaborative culture based on collective intelligence. Our 1,050+ employees, spread across 16 offices in Europe, the Americas, Asia and Middle East are strongly committed to the principles of Responsible Investment and are determined to make finance a force for good in society. Our goal is to deliver excellent investment performance combined with high ethical standards and social responsibility.
At Ardian we invest all of ourselves in building companies that last.

ABOUT DEDALUS
Founded in 1982 in Florence by Giorgio Moretti, Dedalus Group is the leading healthcare and diagnostic software provider in Europe, supporting globally the digital transformation of 6700 Healthcare Organisations and 5700 Labs and Diagnostic centres worldwide, processing its solutions for more than 540 millions of population worldwide. Dedalus offer supports the whole continuum of care, offering open standards-based solutions serving each actor of the Healthcare Ecosystem to provide better care in a healthier planet. Life Flows through our software.
dedalus.com

Media Contact

Kathy Silverstein, On The Marc Media, (301) 545-0108, [email protected], https://onthemarcmedia.com/

SOURCE Dedalus

Health

Pentec Health’s Specialty Care Nurse Fellowship Granted Accreditation With Distinction by the American Nurses Credentialing Center

Leave a comment


Pentec Health, Inc.’s (Pentec) Specialty Care Nurse Fellowship has been granted Accreditation with Distinction, the highest recognition bestowed by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation in Practice Transition Programs.

GLEN MILLS, Pa., Oct. 19, 2023 /PRNewswire-PRWeb/ — Pentec Health, Inc.’s (Pentec) Specialty Care Nurse Fellowship has been granted Accreditation with Distinction, the highest recognition bestowed by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation in Practice Transition Programs.

The accreditation reaffirms Pentec’s position as a trusted provider of specialized, high-skilled infusion nursing and underscores the company’s dedication to delivering outstanding education and training opportunities. Pentec’s patients benefit from expert care and individualized treatment in the setting of their choice. A recent survey underscores just how much patients value that level of care, with 75% of those receiving Pentec Specialty Care services rating their care as a perfect 10.

“This exceptional achievement sets Pentec apart as a leader in the field of home infusion services that specialize in the management of implantable pumps and distinguishes the company among fewer than 10 accredited fellowship programs nationwide,” said Kendra Howard, Executive Vice President of Operations and Clinical Services of Pentec. “The accreditation with the honor of distinction reflects Pentec’s collective commitment to excellence, innovation and continuous improvement. Our dedicated nursing fellows played an integral role in this accomplishment, as did our regional teams who contributed invaluable expertise as preceptors, mentors and coaches.”

Pentec’s Specialty Care nurses provide intrathecal drug delivery for spasticity and pain management in the setting of the patient’s choice, whether in their home or a physician’s office. Pentec’s highly trained nurses apply proper techniques to safely and successfully perform more than 20,000 implanted pump refills and adjustments annually. The care of Pentec nurses for the whole patient involves providing comprehensive physical assessments and ongoing education including 24/7 access to healthcare professionals and patient advocacy teams.

Pentec’s holistic approach extends beyond the care regimen. The company utilizes a multi-disciplinary approach to enhance outcomes by providing patient-specific compounded, sterile medications monitored and delivered by an expert team of infusion pharmacists in addition to highly skilled nurses. And patients are supported by a dedicated patient services team that removes barriers to care, including expertise in navigating the complexity of insurance coverage, product distribution and clinical support.

Clearly patients appreciate that expertise and level of specialty care. The 1,190 intrathecal care patients who participated in a recent patient satisfaction survey gave Pentec a 9.6 overall patient satisfaction score (on a 10-point scale). Overall, 74-88% of intrathecal patients expressed strong agreement with positive statements about Pentec’s timeliness, clear and understandable explanations, trust, respect, care and concern, reliability, coordination of care and safety.

Many patients felt compelled to add comments expressing appreciation for Pentec’s nurses and the company’s care in general.

  • “My nurse has always been there. She has not missed a single appointment over the years, making the nearly 3-hour trip through some of the worst snowstorms the Midwest threw at us. She made every appointment throughout the 3-plus years of COVID. I am truly grateful for her unselfish dedication.”

A Complex Care provider, Pentec provides clinical nutrition – including medical foods and renal nutrition – in addition to specialty infusion care. Pentec is committed to solving and simplifying complex care challenges not addressed by other providers.

About Pentec Health
Pentec Health is committed to solving and simplifying complex care challenges to better meet patient and provider needs. Pentec’s unique solutions, based on empathy, technical expertise, and clinical collaboration, deliver exceptional results through proven delivery models that reduce administrative burdens and improve outcomes through trusted, long-term relationships. Pentec Health serves more than 11,000 patients living with complex medical conditions, with care provided across the nation by more than 350 clinicians.

Media Contact

Jeremy Krick, Pentec Health, (224) 483-4419, [email protected], https://pentechealth.com/ 

Julia Cremin, (331) 333-2928, [email protected]

SOURCE Pentec Health

Health

Global Genes and the Rare Disease Diversity Coalition Expand Effort to Accelerate Diagnosis of Rare Disease in Underserved Communities

Leave a comment


The new phase of the initiative focuses on the creation of educational materials aimed at community health workers engaged with Black, Latinx, and other minoritized communities within Kansas City, KS and Birmingham, AL metro areas. These materials will be utilized in teaching community health workers about rare diseases broadly, the importance of family histories, the role of genetic counseling, and when and how people can seek out genetic testing.

“People living with rare genetic diseases can go for years without obtaining an accurate diagnosis for their conditions and this delay can be much longer for people from historically underserved communities,” said Shruti Mitkus, Director of Genetic Education and Navigation for Global Genes, and Chair of an RDDC working group, Delays in Diagnosis. “By working with community health workers who are embedded in the communities they serve, this initiative will go a long way in increasing awareness of rare diseases at the grassroots level and help accelerate the path to a diagnosis and treatment.”

The first phase of the initiative, which began in 2022, involved a social media-driven, online campaign. Global Genes and RDDC created culturally-appropriate educational content that addressed the importance of family history, information about newborn screening, when to consider genetic testing, and how a genetic counselor may be able to help. Members of the RDDC Delays in Diagnosis working group, which included patients, caregivers, and health and diversity advocates who have extensive experience working with underserved communities, reviewed the campaign materials and provided input.

“In the case of many rare diseases, early treatment can be essential to minimizing the damage disease causes and improving the quality of life for people with these conditions. Knowing your family’s health history can help people recognize signs of a possible genetic disease and the need to pursue testing for themselves or a family member so they can start treatment before a condition progresses,” said Jenifer Ngo Waldrop, executive director of the RDDC. “Sometimes this can be a tough conversation, but it can give people important knowledge that can save lives, make our healthcare system less unfair, and stop needless suffering by letting them know when to get genetic testing.”

To learn more, visit http://www.knowyourfamilyhistory.org or http://www.conozcasuhistoriafamiliar.org.

About Global Genes
Global Genes is a 501(c)(3) leading international non-profit organization that is establishing a globally connected community committed to overcoming the challenges of rare disease. Together with our partners, we help people find and build communities, gain access to information and resources, and provide hope and support for the more than 400 million people affected by rare disease around the globe. If you or someone you love has a rare disease or are searching for a diagnosis, contact Global Genes at 949-248-RARE or visit our Resource Hub.

About Rare Disease Diversity Coalition
Black Women’s Health Imperative launched the Rare Disease Diversity Coalition to address the extraordinary challenges faced by rare disease patients of color. The Coalition brings together rare disease experts, health and diversity advocates, and industry leaders to identify and advocate for evidence-based solutions to alleviate the disproportionate burden of rare diseases on communities of color. The Rare Disease Diversity Coalition is focused on reducing racial disparities in the rare disease community. The Coalition’s work is led by BWHI and a leadership steering committee composed of advocacy, community, and industry leaders. Our leaders focus on reducing racial disparities in the rare disease community, identifying, and advocating for evidence-based solutions to alleviate the disproportionate burden of rare diseases on communities of color, and helping achieve greater equality within the rare disease community.

To learn more, visit: https://www.rarediseasediversity.org/

Media Contact

Lauren Alford, Global Genes, 949.248.7273, [email protected], www.globalgenes.org

D.O. Randolph, RDDC, 888.834.8451, [email protected], https://www.rarediseasediversity.org/

SOURCE Global Genes

Health

Aprio Appoints Trent Watrous to Lead Firm’s National Dental Segment

Leave a comment


“Trent is well-positioned to lead our National Dental Segment as we provide innovative techniques that support our clients and improve patient care,” said Richard Kopelman, Aprio CEO & Managing Partner. “As segment leader, Trent will amplify Aprio as the single source growth partner for dental practices of all sizes, assisting owners in achieving sustainable growth and success.”

“I’m honored to have the opportunity to lead our talented team as we advise top dental practices in the U.S. As we look toward 2024 and beyond, I believe we will continue to see an increase in the number of new practice start-ups, while multi-office practice owners will continue to seek support on maximizing their investments. Aprio’s National Dental Team is strategically positioned to work alongside clients to help them achieve their business goals amid today’s unpredictable economy,” said Trent.

Trent regularly shares his industry expertise with dental audiences across the U.S. He is a member of the American Institute of Certified Public Accountants, the National Association of Certified Valuators and Analysts, and the Association of Certified Fraud Examiners. In addition to being a certified public accountant, he is also a Certified Exit Planning Advisor and is the former president of the West Tennessee Society of Certified Public Accountants. Trent is a widely recognized public speaker and recently delivered presentations to dental professionals across the southeast focused on creating financial success through organizational modifications and practice transitions.

Aprio’s full suite of dental practice offerings include traditional tax and accounting services, practice valuation and transition planning, wealth management integration, payer-mix optimization, due diligence and financial management. Additionally, Aprio’s dental team provides dentists with managed accounting services and real-time access to their financials through a customized dashboard. Using Aprio’s technologies, dentists can harness the power of timely, accurate and meaningful financial insights to make better, faster business decisions to stay focused on providing the best care to their patients.

For more information about Aprio’s National Dental Team, visit https://www.aprio.com/industries/dental-industry/.

For more information about Trent Watrous, visit https://www.aprio.com/people/trenton-watrous/

About Aprio: 
Aprio is a premier, full-service business advisory and accounting firm that advises clients and associates on how to achieve what’s next. Aprio’s associates work as integrated teams across advisory, audit, tax, outsourcing, talent solutions and private client services, bringing the best thinking and personal commitment to each client. Across practices, Aprio brings together proven expertise, deep understanding and strategic foresight for industries including Manufacturing and Distribution; Non-Profit and Education; Professional Services; Real Estate; Construction; Retail, Franchise and Hospitality; Government Contracting, and Technology and Blockchain. Aprio has grown to over 1,800 team members. To serve clients wherever life or business may take them, Aprio’s teams speak more than 60 languages and work with clients in over 50 countries. For more, visit http://www.aprio.com/.

Follow Aprio:
Aprio Website: https://www.aprio.com/
Aprio Careers: https://www.careers.aprio.com/
LinkedIn: https://www.linkedin.com/company/aprio
Facebook: https://www.facebook.com/aprioadvisors
Twitter: https://twitter.com/AprioAdvisors
Instagram: https://www.instagram.com/aprioadvisors/

Media Contact

Leslie Bashuk, Aprio,LLP, 4048929651, [email protected], www.aprio.com

Twitter Facebook

SOURCE Aprio,LLP



Health: Psychology

Dr. Rod J. Rohrich Recognized as Best Liposuction Surgeon in the United States by Newsweek

Leave a comment


These lists were developed as the result of a national survey with more than 2,000 medical experts from doctors, surgeons, plastic surgery clinic managers, and health care professionals working in plastic surgery. During the survey period, over 8,400 votes were collected and analyzed for each cosmetic surgery procedure. Participants were asked to name the leading plastic surgeons for each cosmetic procedure in their own state as well as provide the same for out-of-state surgeons. The recommendations portion of the national survey counts as 85% of the total overall scores.

The participants were then asked to assess the quality of care (e.g., consultation with doctor, complications, follow-up care, outcome) to further differentiate the perceived reputation of each plastic surgeon. These answers, along with accreditation statuses were used to calculate the associated quality score portion, which weighs as the remaining 15% of the total overall scores. 

In the end, the survey results identified 358 individual surgeons which were then ranked into lists of the top 150 in each of the five specialties, with the specific rankings based on their total overall score.

Dr. Rohrich received the highest overall score and thus was ranked at the top of the list as the number one best liposuction plastic surgeon in the country. Dr. Rohrich also appears in each of the other procedure ranked lists; number one in facelift, number one in eyelid surgery, number one in rhinoplasty, as well as number three in the breast augmentation category. 

Dr. Rohrich uses an advanced technique of body contouring surgery combining ultrasound-assisted liposuction to obtain more uniform results, with a super-wet technique of liposuction to enhance overall safety. He has written extensively on this procedure and has demonstrated and taught this technique to thousands of plastic surgeons worldwide.

“Every person has their own unique physical characteristics and anatomy,” says Dr. Rohrich. “It is imperative that prospective patients have an honest discussion with their plastic surgeon regarding goals and expectations in order to ensure the most successful outcomes. Liposuction is an art and a science, as is all of plastic surgery.”

About Rod J. Rohrich, M.D., F.A.C.S.

Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He was named the top plastic surgeon in America by Newsweek in both rhinoplasty and facelift surgery in 2021, 2022 and 2023. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

He is the immediate past (after serving for 18 years) Editor-in-Chief of the most respected global peer reviewed plastic surgery journal – the Plastic and Reconstructive Surgery Journal. He is Founding Editor-in-Chief/Editor Emeritus of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 1000 peer reviewed articles and seven textbooks in plastic surgery including a best-selling medical book entitled The Facial Danger Zones. Dr. Rohrich recently published an innovative cosmetic surgery video atlas, Cosmetic Surgery by the Masters.

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America’s best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession’s highest honors, the Plastic Surgery Foundation (PSF) Distinguished Service Award, which recognizes his contributions to education in plastic surgery. In addition, he has also been recognized by the PSF with the Plastic Surgery Foundation Distinguished Career Researcher Award for his contributions to plastic surgery research and innovations. He is also the recipient of the ASPS 2022 Honorary Citation.

Media Contact

Rod J. Rohrich, MD, Dallas Plastic Surgery Institute, (214) 821-9114, [email protected], https://drrohrich.com/

SOURCE Dallas Plastic Surgery Institute

Health

Launching Silient, a New Company Designed to Revolutionize Cold Water Immersion Therapy with an Innovative On-Demand Solution to Existing Showers and Baths

Leave a comment


“The inception of Silient marks a groundbreaking advancement, not only for individuals seeking the advantageous effects of cold therapy but also for the healthcare industry at large, as it introduces an entirely novel approach to the application of cold therapy,” said Dr. Jon Opraseuth, MD, South Shore Hospital. “While numerous cold therapy options, like cold tubs, exist in the market, their hygienic concerns and potential side effects are noteworthy. Silient has pioneered an innovative solution to optimize the cold therapy experience while harnessing the full spectrum of therapeutic benefits.”

Similar to hot water heaters, Silient is a new category of home appliance that chills water from the home’s fresh water supply down as cold as 40°F for multiple on-demand sessions throughout the day. The novel approach provides the option of cold showers or baths first thing in the morning to supercharge the day, or immediately after a sweaty workout to reduce inflammation and improve recovery time.

“We believe that challenging oneself leads to incredible achievements. With Silient, we reimagined cold therapy to make it more accessible, convenient, and effective for everyone,” said Mark Palchak, founder and CEO, Silient. “This launch signifies a pivotal moment in the wellness space, as our product offers cold therapy in the comfort of the existing bathroom.”

Unlike traditional cold therapy methods that often require specialized equipment or ice baths, Silient offers a seamless and innovative solution that leverages existing showers and baths. Customers can now indulge in the benefits of cold therapy without extensive maintenance. With Silient, users have the power to activate on-demand cold therapy sessions right from their smartphones, creating a more accessible and efficient way to experience this transformative practice.

According to a report by Transparency Market Research, a global market research company, the cold plunge market is predicted to accelerate to a market size of US $550.1 Million by 2031 from US $378.0 Million in 2022 – a 46.25% increase.

Cold plunging is one aspect of cold water therapy or cold water immersion, which is a practice that involves immersing oneself in cold water temperatures, usually for physical and mental health benefits such as enhanced mental focus, reduced depression symptoms, and faster recovery from tough workouts through reduced muscle inflammation. Cold therapy may have a positive effect on stress management as well.

The key features of the Silient cold therapy system include:

  • On-Demand Convenience: The benefits of cold immersion therapy in a user’s shower or bath.
  • Effortless Operation: With the touch of a button on a smartphone, Silient immediately delivers chilled water to your showers and baths. Water temperature is programmable, as cold as 40°F. After use, the water is rechilled to the desired temperature and stored in a cold tank for the next on-demand session.
  • Easy Installation: Silient manages installation, and seamlessly integrates into a user’s home plumbing, taking up minimal space and requiring just two plumbing connections and a standard outlet.
  • No Maintenance Required: No water changes or filter replacements necessary, providing a hassle-free cold therapy experience.

“I needed it, I couldn’t find it, so I built it,” added Palchak, about the driving force behind Silient’s inception. “This sentiment underscores the company’s commitment to providing individuals with a simple yet effective way to enhance their well-being. The launch of Silient’s innovative cold therapy solution is poised to reshape the industry and inspire individuals to embrace the power of cold therapy for improved mental and physical performance.”

For more information on Silient, please visit www.silient.com or instagram.com/be.silient

About Silient:

Silient is a trailblazing company dedicated to reimagining wellness practices and enhancing the way individuals engage with cold therapy. By introducing an innovative on-demand solution that makes cold therapy as simple as opening an app and stepping into the home’s existing shower or bath, Silient empowers individuals to embrace the transformative benefits of cold immersion therapy conveniently and effectively. Silient is committed to promoting peak performance, mental focus, and overall well-being through its revolutionary approach to cold therapy. For more information, please visit www.silient.com.

Media Contact

Erin Farrell-Talbot, Silient, 1 9172329309, [email protected], www.silient.com

SOURCE Silient



Health

Mimio Health Commercially Launches Groundbreaking Biomimetic Based on the Science of Fasting to Promote Cellular Health and Longevity

Leave a comment


Fasting has been shown across thousands of studies to be one of the most powerful ways to enhance health and promote longevity. Using fasting as a roadmap, Mimio Health’s biomimetic research has studied and decoded the changes that happen in the body to activate this innate longevity bio-program.

“Biomimetics seek inspiration from nature, where millions of years of evolution have resulted in highly efficient and effective solutions to various problems. Focusing on harnessing each individual’s own biology, we have closely studied the complex interplay of molecules along key pathways in the body and their compounding cellular benefits that are naturally activated during fasting,” said founder and CEO, Dr. Chris Rhodes. “While fasting has extraordinary scientific backing to provide health and longevity benefits, it can be a difficult long-term lifestyle, and many people who do fast are not unlocking the full benefits. With Mimio, we have been able to elevate the same beneficial bioactive metabolites that are produced during a prolonged fast without needing to skip a meal.”

By mimicking our bodies’ natural processes, Mimio’s biomimetic is designed to upregulate and enhance multiple cellular systems, such as autophagy, metabolic efficiency, and cellular repair and protection, that are typically activated during fasting. Based on years of clinical research at UC Davis studying the underlying biology of fasting, Mimio’s team discovered their proprietary blend of four bioactives (Spermidine, Nicotinamide, Palmitoylethanolamide (PEA), and Oleoylethanolamide (OEA)) that were uniquely elevated in the body during a 36-hour fast. Together, these fasting metabolites work synergistically to activate the cell’s built-in health pathways and unlock both the body’s innate regenerative abilities and compounding cellular benefits without needing to skip a meal.

“Our scientific mission to study, decode, and activate human biology has led us to this remarkable discovery, with much more to come,” continued Dr. Rhodes. “The potential of our biomimetic research to uncover safe and effective bioactive molecules with direct impacts on human health is unparalleled and I can’t wait for what’s on the horizon. I’m humbled to be in a position where my research is making a difference in people’s daily wellness, allowing them to harness the power of their own biology to live fuller, healthier lives.”

The science behind Mimio is validated by a recent peer-reviewed clinical study authored by Dr. Chris Rhodes et al. and published by The American Journal of Clinical Nutrition. Moreover, the bioactive ingredients in Mimio’s formulation have been validated in over 100 clinical studies to achieve whole-body benefits.

“Mimio is a truly game-changing company in the human health and optimization space. As an ultrarunner always looking for a performance edge, I am faced with some of the most demanding physical challenges in the world,” said Charlie Engle, American ultramarathon runner and author. “I’m consistently impressed with Mimio’s ability to enhance my energy, motivation, endurance, and recovery.”

In addition to their new formulation, Mimio Health also announced a $1.75M Seed round led by Better Ventures, with participation by SOSV, Thia Ventures, What If Ventures, R42, and Gaingels. With the new funds, Mimio Health will continue to expand their product lines, perform additional clinical research, and continue their discovery efforts to identify novel biomimetic formulations.

Mimio is available now for purchase at http://www.mimiohealth.com.

About Mimio Health

Mimio Health is the biomimetic human health company. We harness the power of human biology to supercharge the body’s natural restorative abilities.
Our flagship product, Mimio, is a biomimetic designed to activate our cells’ built-in regenerative abilities to clean, repair, and protect themselves. By tapping into thousands of years of evolutionary knowledge about how key molecules are designed to optimally interact, Mimio’s biomimetic ingredients work together to upregulate and enhance various cellular processes that were previously only accessible through fasting. The resulting physical and cognitive benefits include improved metabolic health, increased energy and performance, enhanced mood and focus, balanced inflammatory responses, and optimized healthy aging.
Mimio seamlessly blends into your daily care routine, whether you currently fast and are looking to enhance the results, or are simply looking for a way to take care of your body at a cellular level without skipping a single meal.

Mimio’s founder, Dr. Chris Rhodes’ scientific curiosity has always led him back to longevity. Mimio was inspired by his doctorate research and study of the underlying biology of fasting and its impact on longevity.

To learn more or to try Mimio yourself, please visit: mimiohealth.com.

Mimio Health. Your biology. Your superpower.

Media Contact

Cameron Gordon, JDI, (410) 504-9380, [email protected]

SOURCE JDI

Health

How to Prepare and Analyze your Lab Samples for Timely Clinical Decisions, Upcoming Webinar Hosted by Xtalks

Leave a comment


How do you choose labs that move fast enough in this complex environment for the lives that depend on them?

This webinar is part 3 of a multi-part series addressing key challenges facing sponsors of clinical trials and features an expert panel discussion including Ziad Peerwani, MD, Medical Director, Cleveland Clinic Laboratories; Hilmar Wisplinghoff, MD, Head of Microbiology, Labor Dr. Wisplinghoff; and Cindy Markham, Chief Commercial Officer, LabConnect. Join this webinar to gain valuable insights into how pathology & laboratory medicine can be vital in diagnosing, treating, and monitoring disease. Attendees will also learn how to accelerate their trial through advancements in molecular diagnostics, testing methodologies and automation.

Join Ziad Peerwani, MD, Medical Director, Cleveland Clinic Laboratories; Hilmar Wisplinghoff, MD, Head of Microbiology, Labor Dr. Wisplinghoff; and Cindy Markham, Chief Commercial Officer, LabConnect, for the live webinar on Monday, November 6, 2023, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit How to Prepare and Analyze your Lab Samples for Timely Clinical Decisions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected] 

SOURCE Xtalks

Health

3 Keys to Designing Representative Clinical Trials, Upcoming Webinar Hosted by Xtalks

Leave a comment


To help address these challenges, Jen Lamppa, PhD, will be hosting this webinar with guest speaker, Jacob Milliron, PharmD. Jacob is a Senior Real-World Data and Solutions Director at Inovalon and Jen serves as the Assistant Vice President of Clinical Analytics in Inovalon’s Insights.

During this webinar, the speakers will discuss integrating insights to inform clinical strategy for underrepresented patients. Attendees will have the opportunity to gain valuable insights and knowledge on how to use real-world data analytics solutions to promote DEI in clinical trials. Specifically, the webinar will cover topics such as obtaining insights into the treatment pathways for diverse populations, identifying ways to increase visibility into relevant social determinants of health (SDOH) barriers in underrepresented populations and acquiring tips on how to locate meaningful data on where and who is providing care for diverse populations.

Register for this webinar to gain valuable and actionable insights to promote DEI across the healthcare ecosystem. Join the featured speakers and be part of the impact that SDOH data has on the delivery of care, access to health services and clinical trials and patient outcomes.

Join experts from Inovalon, Jen Lamppa, PhD, AVP, Clinical Analytics; and Jacob Milliron, PharmD, MHA, Senior Real-World Data and Solutions Director, for the live webinar on Thursday, October 26, 2023, at 1pm EDT (7pm CEST/EU-Central).

For more information, or to register for this event, visit Harnessing Real-World Data for DEI: 3 Keys to Designing Representative Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks